Skip to main content
. 2016 May 2;7(24):36655–36665. doi: 10.18632/oncotarget.9131

Figure 2. Immunohistochemical analysis of FGF9 expression and survival curves in patients with GC according to FGF9 levels.

Figure 2

A. High FGF9 expression in gastric adenocarcinoma and low expression in corresponding non-cancerous gastric tissues B. High FGF9 expression in gastric adenocarcinoma, part of signet-ring cell carcinoma and low expression in corresponding non-cancerous gastric tissues C. and low FGF9 expression in corresponding non-cancerous gastric tissues D. High FGF9 expression in gastric tubular adenocarcinoma E. and low FGF9 expression in corresponding non-cancerous tissues F. The total FGF9 expression score was calculated by multiplying the proportion (%) of cells expressing FGF9 with the intensity score described in Methods. The thick line indicates the median score in each group G. *P < 0.001, FGF9-low group vs. FGF9-high group (Mann–Whitney U-test).